HeLa Kyoto EB3-EGFP
€540.00*
HeLa Kyoto stably expressing EB3-EGFP (End-binding-protein3-Enhanced GFP)
Organism:Human (Homo sapiens)
Cell Type:HeLa Kyoto, human cervix carcinoma cells.
Fluorescence Marker:EB3-EGFP
Morphology:Epithelial-like cells with mosaic stone shape.
Growth Properties:Monolayer, adherent
Percentage of expressing cells:Close to 100%
Expression level:This clonal stable cell line shows some variegation.
Production:This clonal stable cell line was generated by transfection of a circular plasmid (see below) followed by drug resistance selection.
EB3-EGFP localizes throughout the cell cycle only to the plus ends of growing micro tubules. Application: Visualisation of individual microtubules and quantification of microtubule dynamics. DisclaimerThis cell line is licensed to CLS by a partnering university or research institute. The cell line may be subject to individual terms and licensing fees as required by the licensor. Please contact us for further information.
This cell line is licensed to CLS by a university or institute. The sale of this item is subjected to the completion of a Material Transfer Agreement (MTA) by the purchaser. Please contact us for more information.
HeLa Kyoto EB3-EGFP growing
€800.00*
HeLa Kyoto stably expressing EB3-EGFP (End-binding-protein3-Enhanced GFP)
Organism:Human (Homo sapiens)
Cell Type:HeLa Kyoto, human cervix carcinoma cells.
Fluorescence Marker:EB3-EGFP
Morphology:Epithelial-like cells with mosaic stone shape.
Growth Properties:Monolayer, adherent
Percentage of expressing cells:Close to 100%
Expression level:This clonal stable cell line shows some variegation.
Production:This clonal stable cell line was generated by transfection of a circular plasmid (see below) followed by drug resistance selection.
EB3-EGFP localizes throughout the cell cycle only to the plus ends of growing micro tubules. Application: Visualisation of individual microtubules and quantification of microtubule dynamics. DisclaimerThis cell line is licensed to CLS by a partnering university or research institute. The cell line may be subject to individual terms and licensing fees as required by the licensor. Please contact us for further information.
This cell line is licensed to CLS by a university or institute. The sale of this item is subjected to the completion of a Material Transfer Agreement (MTA) by the purchaser. Please contact us for more information.
HeLa Kyoto EGFP-alpha-tubulin/H2B-mCherry
€540.00*
Human cervix carcinoma, transfected with EGFP-alpha-tubulin/H2B m-Cherry
Organism:Human (Homo sapiens)
Cell Type:HeLa Kyoto, human cervix carcinoma cells.
Fluorescence Marker:EGFP-alpha-tubulin and H2B-mCherry
Morphology:Epithelial-like cells with mosaic stone shape.
Growth Properties:Monolayer, adherent
Percentage of expressing cells:Close to 100%
Expression level:This clonal stable cell line shows some variegation.
Production:This clonal stable cell line was generated by transfection of a circular plasmid (see below) followed by drug resistance selection.
DisclaimerThis cell line is licensed to CLS by a partnering university or research institute. The cell line may be subject to individual terms and licensing fees as required by the licensor. Please contact us for further information.
This cell line is licensed to CLS by a university or institute. The sale of this item is subjected to the completion of a Material Transfer Agreement (MTA) by the purchaser. Please contact us for more information.
HeLa Kyoto EGFP-alpha-tubulin/H2B-mCherry growing
€800.00*
Human cervix carcinoma, transfected with EGFP-alpha-tubulin/H2B m-Cherry
Organism:Human (Homo sapiens)
Cell Type:HeLa Kyoto, human cervix carcinoma cells.
Fluorescence Marker:EGFP-alpha-tubulin and H2B-mCherry
Morphology:Epithelial-like cells with mosaic stone shape.
Growth Properties:Monolayer, adherent
Percentage of expressing cells:Close to 100%
Expression level:This clonal stable cell line shows some variegation.
Production:This clonal stable cell line was generated by transfection of a circular plasmid (see below) followed by drug resistance selection.
DisclaimerThis cell line is licensed to CLS by a partnering university or research institute. The cell line may be subject to individual terms and licensing fees as required by the licensor. Please contact us for further information.
This cell line is licensed to CLS by a university or institute. The sale of this item is subjected to the completion of a Material Transfer Agreement (MTA) by the purchaser. Please contact us for more information.
HeLa Kyoto EGFP-Cap-D2
€540.00*
HeLa Kyoto cell line stably expressing EGFP CAP-D2
Organism:Human (Homo sapiens)
Cell Type:HeLa Kyoto, human cervix carcinoma cells.
Fluorescence Marker:EGFP-CAP-D2
Morphology:Epithelial-like cells with mosaic stone shape.
Growth Properties:Monolayer, adherent
Percent of expressing cells:About 80%
Expression level:This clonal stable cell line shows some variegation.
Production:This clonal stable cell line was generated by transfection of a circular plasmid (see below) followed by drug resistance selection.
DisclaimerThis cell line is licensed to CLS by a partnering university or research institute. The cell line may be subject to individual terms and licensing fees as required by the licensor. Please contact us for further information.
This cell line is licensed to CLS by a university or institute. The sale of this item is subjected to the completion of a Material Transfer Agreement (MTA) by the purchaser. Please contact us for more information.
HeLa Kyoto EGFP-Cap-D2 growing
€800.00*
HeLa Kyoto cell line stably expressing EGFP CAP-D2
Organism:Human (Homo sapiens)
Cell Type:HeLa Kyoto, human cervix carcinoma cells.
Fluorescence Marker:EGFP-CAP-D2
Morphology:Epithelial-like cells with mosaic stone shape.
Growth Properties:Monolayer, adherent
Percentage of expressing cells:About 80%
Expression level:This clonal stable cell line shows some variegation.
Production:This clonal stable cell line was generated by transfection of a circular plasmid (see below) followed by drug resistance selection.
DisclaimerThis cell line is licensed to CLS by a partnering university or research institute. The cell line may be subject to individual terms and licensing fees as required by the licensor. Please contact us for further information.
This cell line is licensed to CLS by a university or institute. The sale of this item is subjected to the completion of a Material Transfer Agreement (MTA) by the purchaser. Please contact us for more information.
HeLa Kyoto EGFP-H2B
€540.00*
HeLa Kyoto cell line stably expressing EGFP-H2B
Organism:Human (Homo sapiens)
Cell Type:HeLa Kyoto, human cervix carcinoma cells.
Fluorescence Marker:H2B-EGFP
Morphology:Epithelial-like cells with mosaic stone shape.
Growth Properties:Monolayer, adherent
Percent of expressing cells:close to 100%.
Expression level:This clonal stable cell line shows some variegation.
Production:This clonal stable cell line was generated by transfection of a circular plasmid (see below) followed by drug resistance selection.
DisclaimerThis cell line is licensed to CLS by a partnering university or research institute. The cell line may be subject to individual terms and licensing fees as required by the licensor. Please contact us for further information.
This cell line is licensed to CLS by a university or institute. The sale of this item is subjected to the completion of a Material Transfer Agreement (MTA) by the purchaser. Please contact us for more information.
HeLa Kyoto EGFP-H2B growing
€800.00*
HeLa Kyoto cell line stably expressing EGFP-H2B
Organism:Human (Homo sapiens)
Cell Type:HeLa Kyoto, human cervix carcinoma cells.
Fluorescence Marker:H2B-EGFP
Morphology:Epithelial-like cells with mosaic stone shape.
Growth Properties:Monolayer, adherent
Percent of expressing cells:close to 100%.
Expression level:This clonal stable cell line shows some variegation.
Production:This clonal stable cell line was generated by transfection of a circular plasmid (see below) followed by drug resistance selection.
DisclaimerThis cell line is licensed to CLS by a partnering university or research institute. The cell line may be subject to individual terms and licensing fees as required by the licensor. Please contact us for further information.
This cell line is licensed to CLS by a university or institute. The sale of this item is subjected to the completion of a Material Transfer Agreement (MTA) by the purchaser. Please contact us for more information.
HeLa Kyoto EGFP-Kleisin-beta
€540.00*
Human cervix carcinoma HeLa Kyoto EGFP-Kleisin-b cell line
Organism:Human (Homo sapiens)
Cell Type:HeLa Kyoto, human cervix carcinoma cells.
Fluorescence Marker:EGFP-Kleisin-b
Morphology:Epithelial-like cells with mosaic stone shape.
Growth Properties:Monolayer, adherent
Percent of expressing cells:Close to 100%
Expression level:This clonal stable cell line shows some variegation.
Production:This clonal stable cell line was generated by transfection of a circular plasmid (see below) followed by drug resistance selection.
DisclaimerThis cell line is licensed to CLS by a partnering university or research institute. The cell line may be subject to individual terms and licensing fees as required by the licensor. Please contact us for further information.
This cell line is licensed to CLS by a university or institute. The sale of this item is subjected to the completion of a Material Transfer Agreement (MTA) by the purchaser. Please contact us for more information.
HeLa Kyoto EGFP-Kleisin-beta growing
€800.00*
Human cervix carcinoma HeLa Kyoto EGFP-Kleisin-b cell line
Organism:Human (Homo sapiens)
Cell Type:HeLa Kyoto, human cervix carcinoma cells.
Fluorescence Marker:EGFP-Kleisin-b
Morphology:Epithelial-like cells with mosaic stone shape.
Growth Properties:Monolayer, adherent
Percent of expressing cells:Close to 100%
Expression level:This clonal stable cell line shows some variegation.
Production:This clonal stable cell line was generated by transfection of a circular plasmid (see below) followed by drug resistance selection.
DisclaimerThis cell line is licensed to CLS by a partnering university or research institute. The cell line may be subject to individual terms and licensing fees as required by the licensor. Please contact us for further information.
This cell line is licensed to CLS by a university or institute. The sale of this item is subjected to the completion of a Material Transfer Agreement (MTA) by the purchaser. Please contact us for more information.
HeLa Kyoto EGFP-LaminA/H2B-mCherry
€540.00*
EGFP-LaminA/H2B-mCherry stably transfected in HeLa Kyoto cells
Organism:Human (Homo sapiens)
Cell Type:HeLa Kyoto, human cervix carcinoma cells.
Fluorescence Marker:EGFP-LaminA and H2B-mCherry
Morphology:Epithelial-like cells with mosaic stone shape.
Growth Properties:Monolayer, adherent
Percent of expressing cells: Close to 100%
Expression level:This clonal stable cell line shows some variegation.
Production:This clonal stable cell line was generated by transfection of a circular plasmid (see below) followed by drug resistance selection.
DisclaimerThis cell line is licensed to CLS by a partnering university or research institute. The cell line may be subject to individual terms and licensing fees as required by the licensor. Please contact us for further information.
This cell line is licensed to CLS by a university or institute. The sale of this item is subjected to the completion of a Material Transfer Agreement (MTA) by the purchaser. Please contact us for more information.
HeLa Kyoto EGFP-LaminA/H2B-mCherry growing
€800.00*
EGFP-LaminA/H2B-mCherry stably transfected in HeLa Kyoto cells
Organism:Human (Homo sapiens)
Cell Type:HeLa Kyoto, human cervix carcinoma cells.
Fluorescence Marker:EGFP-LaminA and H2B-mCherry
Morphology:Epithelial-like cells with mosaic stone shape.
Growth Properties:Monolayer, adherent
Percent of expressing cells: Close to 100%
Expression level:This clonal stable cell line shows some variegation.
Production:This clonal stable cell line was generated by transfection of a circular plasmid (see below) followed by drug resistance selection.
DisclaimerThis cell line is licensed to CLS by a partnering university or research institute. The cell line may be subject to individual terms and licensing fees as required by the licensor. Please contact us for further information.
This cell line is licensed to CLS by a university or institute. The sale of this item is subjected to the completion of a Material Transfer Agreement (MTA) by the purchaser. Please contact us for more information.
HeLa Kyoto EGFP-LaminB1/H2B-mCherry
€540.00*
EGFP-LaminB1/H2B-mCherry stably transfected in HeLa Kyoto cells
Organism:Human (Homo sapiens)
Cell Type:HeLa Kyoto, human cervix carcinoma cells.
Fluorescence Marker:EGFP-LaminB1 and H2B-mCherry
Morphology:Epithelial-like cells with mosaic stone shape.
Growth Properties:Monolayer, adherent
Percent of expressing cells: Close to 100%
Expression level:This clonal stable cell line shows some variegation.
Production:This clonal stable cell line was generated by transfection of a circular plasmid (see below) followed by drug resistance selection.
DisclaimerThis cell line is licensed to CLS by a partnering university or research institute. The cell line may be subject to individual terms and licensing fees as required by the licensor. Please contact us for further information.
This cell line is licensed to CLS by a university or institute. The sale of this item is subjected to the completion of a Material Transfer Agreement (MTA) by the purchaser. Please contact us for more information.
HeLa Kyoto EGFP-LaminB1/H2B-mCherry growing
€800.00*
EGFP-LaminB1/H2B-mCherry stably transfected in HeLa Kyoto cells
Organism:Human (Homo sapiens)
Cell Type:HeLa Kyoto, human cervix carcinoma cells.
Fluorescence Marker:EGFP-LaminB1 and H2B-mCherry
Morphology:Epithelial-like cells with mosaic stone shape.
Growth Properties:Monolayer, adherent
Percent of expressing cells: Close to 100%
Expression level:This clonal stable cell line shows some variegation.
Production:This clonal stable cell line was generated by transfection of a circular plasmid (see below) followed by drug resistance selection.
DisclaimerThis cell line is licensed to CLS by a partnering university or research institute. The cell line may be subject to individual terms and licensing fees as required by the licensor. Please contact us for further information.
This cell line is licensed to CLS by a university or institute. The sale of this item is subjected to the completion of a Material Transfer Agreement (MTA) by the purchaser. Please contact us for more information.
HeLa Kyoto Mad2-LAP/H2B-mCherry
€540.00*
Mad2-LAP/H2B-mCherry stably expressing HeLa KyotoHuman cervix carcinoma cells
Organism:Human (Homo sapiens)
Cell Type:HeLa Kyoto, human cervix carcinoma cells.
Fluorescence Marker:Mad2-LAP und H2B-mCherry
Morphology:Epithelial-like cells with mosaic stone shape.
Growth Properties:Monolayer, adherent
Percent of expressing cells:
Expression level:This clonal stable cell line shows some variegation.
Production:This clonal stable cell line was generated by transfection of a circular plasmid (see below) followed by drug resistance selection.
DisclaimerThis cell line is licensed to CLS by a partnering university or research institute. The cell line may be subject to individual terms and licensing fees as required by the licensor. Please contact us for further information.
This cell line is licensed to CLS by a university or institute. The sale of this item is subjected to the completion of a Material Transfer Agreement (MTA) by the purchaser. Please contact us for more information.
HeLa Kyoto Mad2-LAP/H2B-mCherry growing
€800.00*
Mad2-LAP/H2B-mCherry stably expressing HeLa KyotoHuman cervix carcinoma cells
Organism:Human (Homo sapiens)
Cell Type:HeLa Kyoto, human cervix carcinoma cells.
Fluorescence Marker:Mad2-LAP und H2B-mCherry
Morphology:Epithelial-like cells with mosaic stone shape.
Growth Properties:Monolayer, adherent
Percent of expressing cells:
Expression level:This clonal stable cell line shows some variegation.
Production:This clonal stable cell line was generated by transfection of a circular plasmid (see below) followed by drug resistance selection.
DisclaimerThis cell line is licensed to CLS by a partnering university or research institute. The cell line may be subject to individual terms and licensing fees as required by the licensor. Please contact us for further information.
HK-2xCRISPR-CAP-D2-mEGFP no.272-78
€540.00*
Human cervix carcinoma cell line, with endogenous CAP-D2 tagged with mEGFP
Organism:Human (Homo sapiens)
Cell Type:HeLa Kyoto, human cervix carcinoma cells.
Fluorescence Marker:Endogenous CAP-D2 tagged with mEGFP
Morphology:Epithelial-like cells with mosaic stone shape.
Growth Properties:Monolayer, adherent
Percent of expressing cells100%
Expression level:Endogenous levels.
Production:This cell line was generated by CRISPR/CAS9D10A nickases assisted genome editing.
DisclaimerThis cell line is licensed to CLS by a partnering university or research institute. The cell line may be subject to individual terms and licensing fees as required by the licensor. Please contact us for further information.
This cell line is licensed to CLS by a university or institute. The sale of this item is subjected to the completion of a Material Transfer Agreement (MTA) by the purchaser. Please contact us for more information.
HK-2xZFN-mEGFP-Nup107
€540.00*
HeLa Kyoto cells with endogenous Nup107 tagged with mEGFP
Organism:Human (Homo sapiens)
Cell Type:HeLa Kyoto, human cervix carcinoma cells.
Fluorescence Marker:mEGFP-Nup107
Morphology:Epithelial-like cells with mosaic stone shape.
Growth Properties:Monolayer, adherent
Percentage of expressing cells100%
Expression level:This clonal stable cell line shows some variegation.
Production:This clonal stable cell line was generated by genome engineering using zinc finger nucleases.
DisclaimerThis cell line is licensed to CLS by a partnering university or research institute. The cell line may be subject to individual terms and licensing fees as required by the licensor. Please contact us for further information.
This cell line is licensed to CLS by a university or institute. The sale of this item is subjected to the completion of a Material Transfer Agreement (MTA) by the purchaser. Please contact us for more information.